Advertisement
Screener

XBIOTECH INC. (XBIT) Share-based Payment Arrangement, Expense, Tax Benefit

1.3 / 5 stars · 14/53 Roast Me

XBIOTECH INC. Share-based Payment Arrangement, Expense, Tax Benefit

XBIOTECH INC. (XBIT) reported Share-based Payment Arrangement, Expense, Tax Benefit of $0 for the 12-month period ending 2018-12-31, per its 10-K/A filed 2019-03-15.

Discontinued › Expense Statement › Income Tax

us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2019-03-15

  • XBIOTECH INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2016-12-31 was $0.00.
  • XBIOTECH INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2016-09-30 was $0.00.
  • XBIOTECH INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2016-06-30 was $0.00.
  • XBIOTECH INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2016-03-31 was $0.00.
  • XBIOTECH INC. share-based payment arrangement, expense, tax benefit for fiscal 2018 was $0.00.
  • XBIOTECH INC. share-based payment arrangement, expense, tax benefit for fiscal 2017 was $0.00.
  • XBIOTECH INC. share-based payment arrangement, expense, tax benefit for fiscal 2016 was $0.00.
  • XBIOTECH INC. share-based payment arrangement, expense, tax benefit for fiscal 2015 was $0.00.
Period endShare-based Payment Arrangement, Expense, Tax Benefit 3 monthShare-based Payment Arrangement, Expense, Tax Benefit 6 monthShare-based Payment Arrangement, Expense, Tax Benefit 9 monthShare-based Payment Arrangement, Expense, Tax Benefit 12 month
2018-12-31$0.00
10-K/A · filed 2019-03-15
2017-12-31$0.00
10-K/A · filed 2019-03-15
2016-12-31$0.00
derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-03-15
$0.00
derived: sum of 2 quarters · filed 2019-03-15
$0.00
derived: sum of 3 quarters · filed 2019-03-15
$0.00
10-K/A · filed 2019-03-15
2016-09-30$0.00
10-Q · filed 2016-11-14
$0.00
derived: sum of 2 quarters · filed 2016-11-14
$0.00
10-Q · filed 2016-11-14
$0.00
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30$0.00
10-Q · filed 2016-08-12
$0.00
10-Q · filed 2016-08-12
$0.00
derived: sum of 3 quarters · filed 2018-03-16
$0.00
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31$0.00
10-Q · filed 2016-05-13
$0.00
derived: sum of 2 quarters · filed 2018-03-16
$0.00
derived: sum of 3 quarters · filed 2018-03-16
$0.00
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16
$0.00
derived: sum of 2 quarters · filed 2018-03-16
$0.00
derived: sum of 3 quarters · filed 2018-03-16
$0.00
10-K · filed 2018-03-16
2015-09-30$0.00
10-Q · filed 2016-11-14
$0.00
derived: sum of 2 quarters · filed 2016-11-14
$0.00
10-Q · filed 2016-11-14
$0.00
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$0.00
10-Q · filed 2016-08-12
$0.00
10-Q · filed 2016-08-12
$0.00
derived: sum of 3 quarters · filed 2017-03-16
$0.00
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$0.00
10-Q · filed 2016-05-13
$0.00
derived: sum of 2 quarters · filed 2017-03-16
$0.00
derived: sum of 3 quarters · filed 2017-03-16
$0.00
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$0.00
derived: sum of 2 quarters · filed 2017-03-16
$0.00
derived: sum of 3 quarters · filed 2017-03-16
$0.00
10-K · filed 2017-03-16
2014-09-30$0.00
10-Q · filed 2015-11-13
$0.00
derived: sum of 2 quarters · filed 2015-11-13
$0.00
10-Q · filed 2015-11-13
2014-06-30$0.00
10-Q · filed 2015-08-14
$0.00
10-Q · filed 2015-08-14
2013-12-31$0.00
10-K · filed 2016-04-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
HYPERION DEFI, INC. (HYPD)United States$0.065B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95